The aim of this study was to assess whether redosing with a combination of intracavernosal (IC) vasoactive agents could produce a complete erectile response, thereby providing a reliable and reproducible method of dynamic investigation of erectile dysfunction.
Introduction
It is well recognized that sub-optimal erectile responses to intracavernosal injection (ICI) may be seen when investigating men with erectile dysfunction. 1 This may potentially give rise to an incorrect clinical diagnosis. It has been reported through measurement of parameters seen at penile colour Doppler ultrasound and by clinical assessment that improved responses can be achieved and so alter patients diagnostic category. 2 This is of importance to individual patients but also has wider implications for the standardization of tests involving dynamic study of erectile function.
Incomplete responses may be seen due to failure of corporal smooth muscle to relax fully and so produce the best possible erectile response. 3 Unfortunately we cannot quantify this factor directly. Therefore to provide a consistent response investigators have attempted to achieve maximal relaxation. A variety of methods including the use of a combination of intracavernosal vasoactive agents, repeated ICI, self stimulation and audio visual sexual stimulation (VES) have been used.
In this study we continuously monitored penile tumescence and rigidity in an attempt to provide an objective and quanti®able assessment of erectile response. We used both combinations and redosing of intracavernosal agents until no further improvement in erectile response could be achieved. By using VES following this we were able to see if there was still potential for a further increase in penile rigidity. One would expect any further response seen with VES to be missed during routine dynamic investigation of erectile dysfunction.
Method
Forty-eight consecutive patients, who on the basis of medical history, sexual history and clinical examination were thought to have organic erectile dysfunction, were included in this study. All investigations were carried out in a quiet comfortable room. The patients lay on a couch, were undressed from the waist down but covered by a blanket. Two loops of a RigiScan (Dacomed) device were placed around the penis and the machine was linked up to a computer for real-time monitoring.
When the RigiScanner had established a base line as indicated on the computer screen an ICI of 10 micrograms (mcg) prostaglandin E1 (PGE1) was given. Tumescence and rigidity were then monitored for at least 15 min. For the purpose of this study we took a rigidity recording of 70% at either base or tip to indicate full erection. Those who developed a rigidity recording of b 70% in response to ICI received no further stimulation. Those with a rigidity of`70% received a further ICI containing a trimix of PGE1, papaverine and phentolamine (dose dependent on the degree of response, see Table 1 ). The tumescence and rigidity were again monitored for at least 15 min. Those who responded to the second ICI with a rigidity increase of b 5% but not up to 70% in total were given a further ICI of the trimix and monitored as before, no patients received b 3 injections. Finally all patients who did not achieve a rigidity of b 70% in response to ICI were shown a sexually explicit videotape (VES) containing scenes of penetrative heterosexual intercourse. The responses were monitored and recorded on computer screen as before.
During the monitoring periods the patients were alone and reassured that no-one else had access to the test room. They were asked after the VES if they detected a change in quality of erection and if so whether this represented a signi®cant clinical improvement. They were also asked if they found the videotape stimulating, offensive or neither.
Results
The mean age of the 48 patients was 60 y (range 48 ± 75). After the initial ICI, seven patients achieved a full response. The remaining 41 failed to reach a rigidity of 70% and so were redosed with the trimix of vasoactive agents. In response to the second injection 23 had no further increase in rigidity, three achieved a full erection and 15 showed an increase in rigidity of b 5% but not a full erection (`70%). These 15 were given a third ICI, which resulted in a further increase in rigidity in only one.
Thirty-eight were shown VES, of these 22 had no further increase in rigidity and 16 developed b 5% increase (range 5 ± 71%, mean 35%), see Figure 1 . All 16 found this increase clinically detectable and eight said they felt it would have made the difference between a useful and non-useful erection in a recreational setting. The real time graphics for two of the patients in the study who had an improved response to VES can be seen in Figures 2  and 3 . Four of the 22 that did not register an increase in rigidity with VES noticed an improvement in their erectile response. This was found to coincide with an increase in tumescence (range 4 ± 14 mm) without an associated increase in rigidity, no patient had a prolonged erection. Four patients of the 41 redosed had a decline in erectile rigidity of b 5% with the second ICI. The response subsequently Figure 1 Flow diagram showing scheme of redosing followed by VES.
Investigation into erectile response in impotence RD Mills and KK Sethia improved with VES in three but one did not regain the previous rigidity level. Only one patient had a decrease in rigidity of b 5% in response to VES, none found the videotape offensive.
Discussion
Sophisticated methods of investigating erectile dysfunction may not alter the clinical outcome for many patients as currently available methods of treatment are applicable to the majority. 4, 5 There are however a number of patients in whom an accurate assessment of erectile function is necessary as their management may depend upon it. For example patients being considered for implant or vascular surgery for their erectile dysfunction. In such patients it is important to be sure both that the organic cause for their problem has been accurately de®ned and that there is not a signi®cant underlying psychological element which may affect the likely outcome of surgery. Furthermore if we wish to follow up individual patients then it is essential to have accurate reproducible methods of assessment and as new therapeutic techniques are introduced it is important that we are able to assess responses accurately.
The limitations of dynamic investigation of erectile dysfunction have been brought to light in recent years. 6 ± 10 Colour Doppler ultrasound, cavernosometry and pharmacoarteriography are sophisticated techniques and measure accurately the parameters they were designed to measure. However Investigation into erectile response in impotence RD Mills and KK Sethia there remains the fundamental problem of our inability to quantify and so standardize smooth muscle relaxation. Therefore we cannot be sure that the true physiological potential has been achieved during any one investigation. This has led to a wide range of normal values being quoted and poor reproducibility for parameters measured by these techniques. 11 ± 15 As the degree of smooth muscle relaxation cannot be measured current investigative techniques mentioned earlier have concentrated on attempting to achieve maximal relaxation by using combinations of vasoactive agents, repeated ICI, self stimulation and the use of VES. Katlowitz et al 16 demonstrated an improved erectile response to VES in 56.5% of 25 patients after a single ICI. In 13% this improvement was particularly signi®cant as it led to an erection thought to be suf®cient for intercourse. VES alone has also been shown to be valuable technique in the initial assessment of erectile dysfunction, 17, 18 although erectile responses were signi®cantly better if combined with vibrotactile stimulation. Our results con®rm that redosing of vasoactive agents may lead to an improved response. Eighteen (44%) of the 41 who received a second injection using the trimix had an increase in rigidity of b 5%. However if we follow our results further we see that redosing using a combination of drugs, 37 of the 38 reached a fairly constant state of relaxation without full erection. This was manifest by consistent readings of penile rigidity from the RigiScan. Twenty-three of these were redosed once and 15 redosed twice. Despite this 16 (42%) of the 38 still demonstrated a further improvement in erectile response of b 5% increase in rigidity when shown VES. That this is of clinical importance is supported by the fact that all patients could detect an improvement in their erectile response and indeed eight felt this degree of increase in erectile rigidity would make the difference between successful and unsuccessful intercourse. Patient assessment of erectile response has been shown to correlate well with objective assessment. 19 
Conclusions
Our study has shown objectively that one cannot guarantee a maximal erectile response with redosing or combinations of vasoactive agents in a clinical setting. The response may be augmented in up to 33% of patients by using VES, thus representing a more accurate re¯ection of the physiological capacity. This provides one explanation for the wide variation in quoted normal values of dynamic tests of erectile function. We would suggest VES may be incorporated into dynamic assessment of erectile dysfunction if the erectile response is poor without, or if one is undertaking a study involving repeat measurements on an individual at different times.
